MétaCan
Menu
Back to cohort
Record W3162810209 · doi:10.1016/j.ijcard.2021.05.012

Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention

2021· article· en· W3162810209 on OpenAlexfundno aff
Deepak L. Bhatt, Juan Carlos Kaski, Sean J. Delaney, Mirvat Alasnag, Felicita Andreotti, Dominick J. Angiolillo, Albert Ferro, Diana A. Gorog, Alberto Lorenzatti, Mamas A. Mamas, John J. McNeil, José Carlos Nicolau, Philippe Gabríel Steg, Juan Tamargo, Doreen Su‐Yin Tan, Marco Valgimigli

Bibliographic record

VenueInternational Journal of Cardiology · 2021
Typearticle
Languageen
FieldMedicine
TopicAntiplatelet Therapy and Cardiovascular Diseases
Canadian institutionsnot available
FundersSt. Jude MedicalEsperion TherapeuticsHLS TherapeuticsIdorsia PharmaceuticalsMedicines CompanyRegado BiosciencesOsprey MedicalDaiichi-SankyoAstraZenecaAmarin CorporationIronwood Pharmaceuticals, IncorporatedRegeneron PharmaceuticalsDuke Clinical Research InstituteEisaiBoston VA Research InstituteBoston Scientific CorporationEli Lilly and CompanyCleveland ClinicBristol-Myers SquibbCSL BehringBelvoir Media GroupNovo NordiskMyoKardiaDaiichi Sankyo EuropeServierGilead SciencesAmgenPfizerPTC TherapeuticsSanofiAmerican Heart Association
KeywordsMedicinePercutaneous coronary interventionConventional PCIAspirinAcute coronary syndromeInternal medicineGuidelineClopidogrelST segmentCrowdsourcingCardiologyEmergency medicineIntensive care medicineMyocardial infarction

Abstract

fetched live from OpenAlex

Aims Choosing an antiplatelet strategy in patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) at high bleeding risk (HBR), undergoing post-percutaneous coronary intervention (PCI), is complex. We used a unique open-source approach (crowdsourcing) to document if practices varied across a small, global cross-section of antiplatelet prescribers in the post-PCI setting. Methods and results Five-hundred and fifty-nine professionals from 70 countries (the ‘crowd') completed questionnaires containing single- or multi-option and free form questions regarding antiplatelet clinical practice in post-PCI NSTE-ACS patients at HBR. A threshold of 75% defined ‘agreement'. There was strong agreement favouring monotherapy with either aspirin or a P2Y 12 inhibitor following initial DAPT, within the first year (94%). No agreement was reached on the optimal duration of DAPT or choice of monotherapy: responses were in equipoise for shorter (≤3 months, 51%) or longer (≥6 months, 46%) duration, and monotherapy choice (45% aspirin; 53% P2Y 12 inhibitor). Most respondents stated use of guideline-directed tools to assess risk, although clinical judgement was preferred by 32% for assessing bleeding risk and by 46% for thrombotic risk. Conclusion The crowdsourcing methodology showed potential as a tool to assess current practice and variation on a global scale and to achieve a broad demographic representation. These preliminary results indicate a high degree of variation with respect to duration of DAPT, monotherapy drug of choice following DAPT and how thrombotic and bleeding risk are assessed. Further investigations should concentrate on interrogating practice variation between key demographic groups.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.023
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.013
Threshold uncertainty score0.050

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0090.023
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0000.002
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.283
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueInternational Journal of CardiologySame topicAntiplatelet Therapy and Cardiovascular DiseasesFrench-language works237,207